| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2564746 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2014 | 5 Pages |
•Cannabis acutely raises dopamine levels in the striatum.•Chronic use of cannabis is not associated with blunted dopamine release in the striatum.•Chronic use of cannabis is not associated with low D2 receptor expression in the striatum.
Low striatal dopamine D2/3 receptor (D2/3) availability and low ventrostriatal dopamine release have been observed in alcoholism, cocaine and heroin dependence. Multiple studies to date have examined D2 availability in cannabis dependence and have consistently failed to demonstrate alterations. In addition, the response of the dopamine system to an amphetamine challenge and to a stress challenge has also been examined, and did not show alterations. We review these studies here and conclude that cannabis dependence is an exception among commonly abused drugs in that it is not associated with blunting of the dopamine system.
